Bio-engineered Stent Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

  • Single User License $3500

Bio-engineered Stent Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Status : August, 2019 | Medical Devices | PPT format

Report Digest


Global Bio-engineered Stent Market: Overview

The global bio-engineered stent market has grown steadily over the years, due to the advantages it provides to the heart patients. Bio-engineered stents are a type of device which consist of short plastic tube or narrow metal. These devices are extensively used in order to treat blocked arteries. Therefore, bio-engineered stent is gaining its maximum popularity among the patients who are suffering from several types of cardiovascular disorders or diseases such as ischemic heart disease and coronary heart disease.

A wide range of bio-engineered stent are available in market to treat numerous diseases such as peripheral arterial disease, coronary artery disease, carotid artery disease, abdominal aortic aneurysm, renal artery stenosis, and thoracic aortic aneurysm. Such USPs are majorly boosting the global bio-engineered stent market.

From the perspective of materials, the global bio-engineered stent market is segmented into cobalt alloy metal, stainless steel, tantalum, gold, nitinol, and polymers. Among them, the polymer segment showcases the lion’s share in the global bio-engineered stent market. This is due to its immense flexibility and success rates in the cases of different types of cardiovascular diseases. Moreover, bio-engineered stent can be manufactured by bio-erodible polymer, silicone, and polyurethane.

Global Bio-engineered Stent Market: Notable Developments

Some of the key developments highly contouring the shape of the global bio-engineered stent market in a positive way include:

  • In September 2018, one of the renowned company in the global bio-engineered stent market named as Biotronik SE & Co. KG had received the U.S Food and Drug Administration Approval (FDA) for coronary stent system in order to treat the acute coronary artery.
  • In October 2015, the company Medtronic Plc. had tested the drug-filled stent (DFS), where the drug was contained inside a reservoir, which was fixed inside of a bio-engineered stent. This drug was slowly eluted through a small laser-drilled holes in the outer core which was made of metal.

Some of the prominent companies operating in the global bio-engineered stent market are Terumo Corporation, Biotronik SE &Co. KG, Stentys Sao, and Lombard Medical technologies.

Global Bio-engineered Stent Market: Key Growth Drivers

Burgeoning Population Suffering from Renal and Cardiovascular Diseases to Boost Market

Bio-engineered stent plays a crucial role in expanding the blood vessel for preventing a blockage of arteries, especially in cardiovascular diseases. Thus, rising prevalence of different types of coronary heart diseases and growing population suffering from various cardiovascular diseases are propelling expansion in the global bio-engineered stent market. According to American Heart Association, a major population in the U.S is suffering from a few types of heart disorders and diseases, whereas a large number of people are suffering from the after-effects of stroke. According to World Health Organization (WHO), heart diseases have become the highest cause of mortality globally. However, bio-engineered stent acts as an alternative treatment to several cardiovascular diseases which brings the most positive results. Such factors are providing the major impetus to the growth of the global bio-engineered stent market.

Furthermore, apart from a wide range of cardiac problems, rising cases of several other diseases is also contributing demand in the global bio-engineered stent market. Growing prevalence of renal diseases and disorders is also fueling growth in the global bio-engineered stent market. However, governments’ stringent regulations for product type approvals and product type failure are the couple of challenges in the growth of the global bio-engineered stent market. Such challenges are responsible for obstructing the growth of the market. Nonetheless, persistent demand for bio-engineered stent from the healthcare industry in developing and developed regions is believed to overcome these challenges in the near future.

Global Bio-engineered Stent Market: Regional Outlook

With respect to geography, North America is leading the global bio-engineered stent market as the region has witnessed high expenditures in healthcare industry. Along with this, rising cases of cardiac ailments and growing prevalence of obesity are also responsible for fueling demand in the bio-engineered stent market in this region.

The study presents reliable qualitative and quantitative insights into:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand chain of the market
  • Market valuation (revenue and/or volume)
  • Key trends/opportunities/challenges
  • Forces defining present and estimated future state of the competitive landscape
  • Technological developments
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.

Highlights of the report:

  • A detailed analysis of key segments of the market
  • Recent developments in the market’s competitive landscape
  • Detailed analysis of market segments up to second or third level of segmentation
  • Historical, current, and projected future valuation of the market in terms of revenue and/or volume
  • Key business strategies adopted by influential market vendors
  • Outline of the regulatory framework surrounding and governing numerous aspects of the market
  • Growth opportunities in emerging and established markets
  • Recommendations to market players to stay ahead of the competition

Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.

Wish to check Table of Contents of this report?

Click below to Request TOC

Request TOC